Company / Free Cash Flow per Share
Phathom Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.44
FY2025
5-year range
-$4.02 / -$2.40
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#140 of 192
Health Care
What the data says
At $-2.44, Phathom Pharmaceuticals, Inc.'s free cash flow per share ranks #140 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-4.02 in FY2021 to $-2.13 in FY2020.
Based on SEC 10-K filings.
-2.44 in FY2025.
Improved from $-3.36 to $-2.44 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 192 in Health CareTop 73% of 192This company -$2.44 Sector average $3.32
▼
-173.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1.5% year-over-year.
- Ranks #140 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.44 | -1.5% |
| FY2024 | -$2.40 | +28.5% |
| FY2023 | -$3.36 | +11.0% |
| FY2022 | -$3.77 | +6.2% |
| FY2021 | -$4.02 | -88.9% |
| FY2020 | -$2.13 | +34.0% |
| FY2019 | -$3.22 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026